Fig. 4From: High expression of S100A2 predicts poor prognosis in patients with endometrial carcinomaThe independent risk and diagnostic value of S100A2 expression in endometrial carcinoma. (a & b) Kaplan–Meier analysis of overall survival (OS) and disease specific survival (DSS) for patientsBack to article page